Adaptive one-class Gaussian processes allow accurate prioritization of oncology drug targets
Author(s) -
Antonio de Falco,
Zoltán Dezső,
Francesco Ceccarelli,
Luigi Cerulo,
Angelo Ciaramella,
Michele Ceccarelli
Publication year - 2020
Publication title -
bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.599
H-Index - 390
eISSN - 1367-4811
pISSN - 1367-4803
DOI - 10.1093/bioinformatics/btaa968
Subject(s) - computer science , druggability , python (programming language) , prioritization , machine learning , source code , hyperparameter , benchmark (surveying) , class (philosophy) , selection (genetic algorithm) , drug development , set (abstract data type) , gaussian process , artificial intelligence , data mining , gaussian , drug , medicine , biology , pharmacology , programming language , biochemistry , physics , geodesy , management science , quantum mechanics , gene , economics , geography
The cost of drug development has dramatically increased in the last decades, with the number new drugs approved per billion US dollars spent on R&D halving every year or less. The selection and prioritization of targets is one the most influential decisions in drug discovery. Here we present a Gaussian Process model for the prioritization of drug targets cast as a problem of learning with only positive and unlabeled examples.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom